Abbott India Ltd vs Rekvina Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Abbott India Ltd is ₹ 26898 as of 12 May 15:30 . The P/E Ratio of Abbott India Ltd changed from 46.1 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 0.04% over 5 yearsThe P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Abbott India Ltd changed from ₹ 31850 crore on March 2021 to ₹ 65302 crore on March 2025 . This represents a CAGR of 15.44% over 5 yearsThe Market Cap of Rekvina Labs Ltd changed from ₹ 2.39 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Abbott India Ltd for the Mar '26 is ₹ 1785 crore as compare to the Dec '25 revenue of ₹ 1793 crore. This represent the decline of -0.49% The revenue of Rekvina Labs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0.35 crore. This represent the decline of -100% The ebitda of Abbott India Ltd for the Mar '26 is ₹ 556.44 crore as compare to the Dec '25 ebitda of ₹ 533.23 crore. This represent the growth of 4.35% The ebitda of Rekvina Labs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.12 crore. This represent the decline of -100% The net profit of Abbott India Ltd changed from ₹ 328.01 crore to ₹ 394.93 crore over 8 quarters. This represents a CAGR of 9.73% The net profit of Rekvina Labs Ltd changed from ₹ -0.07 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The Dividend Payout of Abbott India Ltd changed from 84.61 % on March 2021 to 71.36 % on March 2025 . This represents a CAGR of -3.35% over 5 yearsThe Dividend Payout of Rekvina Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Abbott India Ltd

Abbott India Ltd Share Price Overview Abbott India Ltd share price history records the movement of the stock in various phases of the market.
Company developments, as well as the general trends in the pharmaceutical industry, have influenced this movement.
As a healthcare-oriented company, the stock tends to respond to fluctuations in the demand of drugs, regulatory activities, and the general mood of investors.
The past performance of the stock gives the investors an idea of how it has reacted to the change in earnings, product portfolio development, and significant company occurrences at various times. Long-Term Performance The stock price performance of Abbott India Ltd has seen phases of fluctuation over time, with a 18% CAGR over the last 10 years.
This reflects movement across different market conditions, with periods of strength and correction.

About Rekvina Labs Ltd

Rekvina Labs Limited was incorporated on 1st November 1988.
From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore.
It is registered in England and Wales as a Public Limited Company.
The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements.
It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products.

FAQs for the comparison of Abbott India Ltd and Rekvina Labs Ltd

Which company has a larger market capitalization, Abbott India Ltd or Rekvina Labs Ltd?

Market cap of Abbott India Ltd is 57,158 Cr while Market cap of Rekvina Labs Ltd is 21 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Rekvina Labs Ltd?

The stock performance of Abbott India Ltd and Rekvina Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Rekvina Labs Ltd?

As of May 12, 2026, the Abbott India Ltd stock price is INR ₹26898.1. On the other hand, Rekvina Labs Ltd stock price is INR ₹35.36.

How do dividend payouts of Abbott India Ltd and Rekvina Labs Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Rekvina Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.